Oren Elmaliah
Vermogen: 20 150 $ op 31-05-2026
Vermogen: 20 150 $ op 31-05-2026
Oren Elmaliah currently works at Presstek LLC, as Chief Financial Officer-Israel from 2017, Enlivex Therapeutics Ltd., as Controller from 2017, and My Size, Inc., as Chief Financial Officer from 2025.
Mr. Elmaliah also formerly worked at My Size, Inc., as Independent Director from 2017 to 2025 and Bioblast Pharma Ltd., as Chief Financial Officer & Controller.
Mr. Elmaliah received his undergraduate degree in 2011 from Tel-Aviv University and graduate degree in 2016 from Tel-Aviv University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
MY SIZE, INC. 0,67% | 21-05-2026 | 32.500 ( 0,67% ) | 20 150 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| ENLIVEX LTD. | Comptroller/Controller/Auditor | 01-02-2017 |
| MY SIZE, INC. | Financieel Directeur/CFO | 01-04-2025 |
Presstek LLC
Presstek LLC Industrial MachineryProducer Manufacturing Manufactures and supplies printing equipment & plates | Corporate Officer/Principal | 01-01-2017 |
| Bedrijven | Functie | Einde |
|---|---|---|
| MY SIZE, INC. | Directeur/Bestuurslid | 06-03-2025 |
Bioblast Pharma Ltd.
Bioblast Pharma Ltd. BiotechnologyHealth Technology Operates as a biopharmaceutical company | Financieel Directeur/CFO | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
Presstek LLC
Presstek LLC Industrial MachineryProducer Manufacturing Manufactures and supplies printing equipment & plates | Producer Manufacturing |
Bioblast Pharma Ltd.
Bioblast Pharma Ltd. BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
Tel-Aviv University
Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
My Size, Inc.
My Size, Inc. Internet Software/ServicesTechnology Services Engages in the development of smart phone application | Technology Services |
Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd. BiotechnologyHealth Technology Develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau